SLIDD, a novel and exceptional technology is composed of three essential ingredients that work independently to ensure the bioavailability of the active drug to the site of action, the COLON. Any drug enveloped with the SLIDD technology is dosed in small quantities and due to the mechanism of action of the components is delivered almost 100% to the colon. This has been proven through multiple studies – both in vitro and clinical.